All Professionals
Overview
Elizabeth Razzano is a partner in the Corporate Department of Paul Hastings and is based in the firm’s Palo Alto office. Her practice focuses on mergers and acquisitions, securities and capital markets, and corporate governance.
Elizabeth represents both public and private companies in a number of different industries, including the aerospace/defense, biotechnology/biopharmaceutical, medical device, software and information technology industries, in a wide range of corporate transactions, including IPOs, registered directs, at-the-market offerings and private debt and equity financings, mergers and acquisitions, de-SPAC transactions, joint ventures and general corporate matters. She also represents Nasdaq and NYSE companies with their periodic reporting requirements and listing qualification issues. Elizabeth regularly advises boards of directors and management of public and private companies regarding corporate governance issues, including the Sarbanes-Oxley Act, the Dodd-Frank Act and the JOBS Act.
Accolades
- Rising Star, Super Lawyers (a distinction given to less than 2.5 percent of lawyers in the state)
Education
- University of San Diego, J.D. (Articles Editor, San Diego Law Review)
- Purdue University, B.S.
Representations
- The investor in the Datavault registered offering for bitcoin treasury.
- Paige.ai in its sale to Tempus AI for $81.25 million.
- Aardvark Therapeutics in its initial public offering.
- Uplift in its sale to Upgrade.
- Scilex Holding Company in its reverse merger (deSPAC) with Vickers Vantage Corp. I, valued at $2.5 billion.
- Alpha Teknova in its initial public offering of $110.4 million of common stock.
- Sorrento Therapeutics in its acquisitions of ACEA Therapeutics and SmartPharm Therapeutics.
- Aterian in its acquisition of various e-commerce business brands.
- Boeing in the acquisition of ForeFlight.
- GE Aviation in its joint venture investment in Avionica.
- GE Aviation in the sale of its aviation manufacturing facility in Santa Ana, California.
- Boeing in the disposition of its marine navigation business in a complex stock and asset sale in the U.S. and eight jurisdictions outside of the U.S.
- GE Healthcare in its sale of Clarient Diagnostic Services in a cash and stock merger valued at $275 million.
- Shuanghui International Holdings Limited, China''s largest meat manufacturer, in its acquisition of Smithfield Foods in a cash merger valued at $7.1 billion.
- Accelrys in its sale of the company to Dassault Systèmes in a cash merger valued at $750 million.
- David Murdock in the going private transaction of Dole Food Company valued at $1.6 billion.
- CDH Investments in its acquisition of a 78.775% stake in Proctor & Gamble’s China-based battery joint venture.
- Gevo in its $62 million follow-on public offering and $40 million convertible notes offering.
- ABC-Mart, Japan''s largest shoe retailer, in its $138 million acquisition of U.S. based LaCrosse Footwear.
- Kratos Defense & Security Solutions in its acquisition of Composite Engineering in a cash and stock merger valued at $115 million.
- Ardea Biosciences in its sale of the company to Astrazeneca PLC in a cash merger valued at $1.3 billion.
- Trimeris in its sale of the company to Synageva BioPharma in a stock-for-stock merger valued at $275 million.
- Kratos Defense & Security Solutions in its acquisition of Integral Systems in a cash and stock merger valued at $225 million.
- Kratos Defense & Security Solutions in its 144A notes offerings for an aggregate of $400 million and follow-on public offerings of an aggregate of $91 million.
- Rural/Metro Corporation in its sale of the company to Warburg Pincus in a cash for stock merger valued at $670 million.
- Kratos Defense & Security Solutions in its acquisition of Herley Industries through an all-cash tender offer and second-step merger valued at $270 million.
- Gevo in its initial public offering of $107 million of common stock in February 2011.
- Kratos Defense & Security Solutions in its acquisition of Henry Bros. Electronics valued at $45 million.
- Accelrys in the acquisition of Symyx Technologies in a stock-for-stock merger valued at $175 million.
- Marvel Entertainment in the sale of the company to The Walt Disney Company in a cash and stock merger valued at over $4 billion.
- Multi-Fineline Electronix in the acquisition of Pelikon, a private limited company of England and Wales.
- Citigroup in the sale of several subsidiaries.
- AviaraDx in the sale of the company to bioMerieux, a publicly traded French company.
- Iomega Corporation in a cash tender offer by EMC Corporation valued at over $200 million.
- Masimo Corporation in its initial public offering of $233 million of common stock in August 2007.
Engagement & Publications
Speaking Engagements
- "M&A Transactions In the Wake of COVID-19," Strafford Publications, Speaker (May 2020)
- "Market Trends," ABA M&A Committee Meeting, Speaker (January 2018)
- "One Year In, 251(h) Has Become M&A Game Changer," Law360, Interviewee (September 2014)
- "Corporate Governance Trends, Forum Selection Bylaws, Social Media Risks, Shareholder Engagement and Shareholder Activism," Association of Corporate Counsel, Speaker (September 2014)
Involvement
- Member – State Bars of California and New York
- Member – American Bar Association